Amanda F. Baker

3.3k total citations
56 papers, 2.7k citations indexed

About

Amanda F. Baker is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Amanda F. Baker has authored 56 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 12 papers in Oncology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Amanda F. Baker's work include Redox biology and oxidative stress (15 papers), Glutathione Transferases and Polymorphisms (9 papers) and MRI in cancer diagnosis (8 papers). Amanda F. Baker is often cited by papers focused on Redox biology and oxidative stress (15 papers), Glutathione Transferases and Polymorphisms (9 papers) and MRI in cancer diagnosis (8 papers). Amanda F. Baker collaborates with scholars based in United States, Belgium and Egypt. Amanda F. Baker's co-authors include Garth Powis, Margaret M. Briehl, Tomislav Dragovich, Claire M. Payne, D. Lynn Kirkpatrick, Ryan Williams, Nathan T. Ihle, Cecilia M. Fenoglio‐Preiser, Neale T. Hanke and Wendy R. Tate and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Amanda F. Baker

55 papers receiving 2.6k citations

Peers

Countries citing papers authored by Amanda F. Baker

Since Specialization

Citations

This map shows the geographic impact of Amanda F. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda F. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda F. Baker more than expected).

Fields of papers citing papers by Amanda F. Baker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda F. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda F. Baker. The network helps show where Amanda F. Baker may publish in the future.

Co-authorship network of co-authors of Amanda F. Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda F. Baker. A scholar is included among the top collaborators of Amanda F. Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda F. Baker. Amanda F. Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mechanistic insights into Rho/MRTF inhibition-induced apoptotic events and prevention of drug resistance in melanoma: implications for the involvement of pirin 2025 ·Frontiers in Pharmacology ·(unknown), Amanda F. Baker, (unknown), (unknown), Richard R. Neubig	0
2	Urinary Kidney Injury Biomarker Profiles in Healthy Individuals and After Nephrotoxic and Ischemic Injury 2025 ·Clinical Pharmacology & Therapeutics ·Sushrut S. Waikar, Robin Mogg, Amanda F. Baker, György Frendl, Michael J. Topper, Scott Adler, Stefan Sultana, (unknown), Nicholas M. P. King, Steven P. Piccoli, (unknown), (unknown), Irene Nunes, Frank D. Sistare	4
3	Characterization of carfilzomib-resistant non-small cell lung cancer cell lines 2018 ·Journal of Cancer Research and Clinical Oncology ·Neale T. Hanke, Elliot Imler, Marilyn T. Marron, Bruce Seligmann, Linda L. Garland, Amanda F. Baker	15
4	Evaluation of a Hypoxia Regulated Gene Panel in Ovarian Cancer 2015 ·Cancer Microenvironment ·Amanda F. Baker, (unknown), Ritu Pandey, (unknown), Haiyan Cui, Denise J. Roe, Setsuko K. Chambers	11
5	The anti-tumor efficacy of 2-deoxyglucose and D-allose are enhanced with p38 inhibition in pancreatic and ovarian cell lines 2015 ·Journal of Experimental & Clinical Cancer Research ·(unknown), Neale T. Hanke, (unknown), (unknown), Amanda F. Baker	38
6	Assessment of carbonic anhydrase IX expression and extracellular pH in B-cell lymphoma cell line models 2014 ·Leukemia & lymphoma ·Liu Qi Chen, Christine M. Howison, Catherine Spier, Alison Stopeck, (unknown), Mark D. Pagel, Amanda F. Baker	31
7	Carfilzomib demonstrates broad anti-tumor activity in pre-clinical non-small cell and small cell lung cancer models 2014 ·Journal of Experimental & Clinical Cancer Research ·Amanda F. Baker, Neale T. Hanke, (unknown), (unknown), Janet L. Anderl, Linda L. Garland	33
8	Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001) 2014 ·Cancer Chemotherapy and Pharmacology ·Tomislav Dragovich, Daniel A. Laheru, Farshid Dayyani, Vanessa Bolejack, Lee Smith, (unknown), Howard A. Burris, Peter J. Rosen, Manuel Hidalgo, Paul S. Ritch, Amanda F. Baker, Natarajan Raghunand, John Crowley, Daniel D. Von Hoff	56
9	Evaluation of the “Steal” Phenomenon on the Efficacy of Hypoxia Activated Prodrug TH-302 in Pancreatic Cancer 2014 ·PLoS ONE ·Kate Bailey, Heather H. Cornnell, Arig Ibrahim‐Hashim, Jonathan W. Wojtkowiak, Charles P. Hart, Xiaomeng Zhang, (unknown), Gary V. Martinez, Amanda F. Baker, Robert J. Gillies	23
10	IL-6 Stimulates STAT3 and Pim-1 Kinase in Pancreatic Cancer Cell Lines 2012 ·Pancreas ·(unknown), Neale T. Hanke, Erin A. Maine, Amanda F. Baker	48
11	TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules 2012 ·Cancer Chemotherapy and Pharmacology ·Qian Liu, Jessica D. Sun, Jingli Wang, Dharmendra Ahluwalia, Amanda F. Baker, Lee D. Cranmer, Damien Ferraro, Yan Wang, (unknown), W. S. Ammons, John G. Curd, Mark D. Matteucci, Charles P. Hart	86
12	Imaging biomarkers to monitor response to the hypoxia-activated prodrug TH-302 in the MiaPaCa2 flank xenograft model 2012 ·Magnetic Resonance Imaging ·(unknown), Yuguo Li, Jean-Philippe Galons, Heather H. Cornnell, Robert J. Gillies, Mark D. Pagel, Amanda F. Baker	20
13	A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination 2010 ·Cancer Chemotherapy and Pharmacology ·Ramesh K. Ramanathan, James L. Abbruzzese, Tomislav Dragovich, Lynn Kirkpatrick, Jose Guillen, Amanda F. Baker, Linda Pestano, Sylvan Green, Daniel D. Von Hoff	104
14	Identification of Thioredoxin-Interacting Protein 1 as a Hypoxia-Inducible Factor 1α-Induced Gene in Pancreatic Cancer 2008 ·Pancreas ·Amanda F. Baker, Mei Yee Koh, Ryan Williams, Brian P. James, Huamin Wang, Wendy R. Tate, Alfred Gallegos, Daniel D. Von Hoff, Haiyong Han, Garth Powis	45
15	The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma 2006 ·Journal of Laboratory and Clinical Medicine ·Amanda F. Baker, Tomislav Dragovich, Wendy R. Tate, Ramesh K. Ramanathan, Denise J. Roe, Chiu‐Hsieh Hsu, D. Lynn Kirkpatrick, Garth Powis	77
16	Dynamic Contrast-Enhanced and Diffusion MRI Show Rapid and Dramatic Changes in Tumor Microenvironment in Response to Inhibition of HIF-1α Using PX-478 2005 ·Neoplasia ·Bénédicte F. Jordan, Matthew Runquist, Natarajan Raghunand, Amanda F. Baker, Ryan Williams, Lynn Kirkpatrick, Garth Powis, Robert J. Gillies	107
17	Thioredoxin Peroxidase-1 (peroxiredoxin-1) Is Increased in Thioredoxin-1 Transfected Cells and Results in Enhanced Protection against Apoptosis Caused by Hydrogen Peroxide but Not by Other Agents Including Dexamethasone, Etoposide, and Doxorubicin 2001 ·Archives of Biochemistry and Biophysics ·Margareta Berggren, Bryan Husbeck, Betty K. Samulitis, Amanda F. Baker, Alfred Gallegos, Garth Powis	100
18	Drug interactions with the taxanes: clinical implications 2001 ·Cancer Treatment Reviews ·Amanda F. Baker, R T Dorr	37
19	Thioredoxin redox control of cell growth and death and the effects of inhibitors 1998 ·Chemico-Biological Interactions ·Garth Powis, D. Lynn Kirkpatrick, M. Martín Angulo, Amanda F. Baker	87
20	Redox Signaling and the Control of Cell Growth and Death 1996 ·Advances in pharmacology ·Garth Powis, John R. Gasdaska, Amanda F. Baker	104

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact